MARK2 and breast cancer: The serine/threonine kinase AKT, also known as protein kinase B, is supposed to have an important role for bone metastasis of breast cancer [27,28]; the AKT signaling is frequently dysregulated in triple negative breast cancer among plenty of other important signaling pathways [29,30].